Skip to main content
. 2017 Aug 18;130(21):2283–2294. doi: 10.1182/blood-2017-02-767384

Figure 4.

Figure 4.

iPAI-1 determines the activity of MT1-MMP–dependent HSPC migration. Percentages of migrated Linc-kit+ cells in in vitro (A) or in vivo (B) experiments (n = 6 each). rPAI-1, recombinant plasminogen activator inhibitor-1. Means ± SD are shown in each bar graph.